ICCC · Insider Trading
Immucell Corp
Every open-market purchase and sale reported by ICCC officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-22 | Boekhorst Paul Francis Olivier te | President and CEO | Buy | +8,000 | +$75.96K |
| 2026-04-16 | Paul R Wainman | Director | A | +11,933 deriv. | — |
| 2026-04-16 | Gloria F Basse | Director | A | +11,933 deriv. | — |
| 2026-04-16 | David Scott Tomsche | Director | A | +11,933 deriv. | — |
| 2026-04-16 | Kathy V Turner | Director | A | +17,899 deriv. | — |
| 2026-04-14 | Bryan K. Gathagan | Director | A | +10,000 deriv. | — |
| 2026-04-14 | Gloria F Basse | Director | A | +10,000 deriv. | — |
| 2026-04-14 | Steven T. Rosgen | Director | A | +10,000 deriv. | — |
| 2026-04-14 | Bobbi Jo Brockmann | VP of Sales and Marketing | A | +5,000 deriv. | — |
| 2026-04-14 | Paul R Wainman | Director | A | +10,000 deriv. | — |
| 2026-04-14 | David Scott Tomsche | Director | A | +10,000 deriv. | — |
| 2026-03-24 | Michael F Brigham | Director | MIXED | +948 | +$4 |
| 2026-03-23 | Boekhorst Paul Francis Olivier te | President and CEO | A | +109,500 deriv. | — |
| 2026-01-29 | Timothy C Fiori | Chief Financial Officer | A | +120,000 deriv. | — |
| 2026-01-29 | Bobbi Jo Brockmann | VP of Sales and Marketing | A | +100,000 deriv. | — |
| 2026-01-29 | Boekhorst Paul Francis Olivier te | President and CEO | A | +110,000 deriv. | — |
| 2025-12-04 | Boekhorst Paul Francis Olivier te | President and CEO | Buy | +6,030 | +$31.53K |
| 2025-12-03 | Boekhorst Paul Francis Olivier te | President and CEO | Buy | +9,785 | +$48.59K |
| 2025-11-28 | David Scott Tomsche | Director | Buy | +3,266 | +$15.55K |
| 2025-11-12 | Boekhorst Paul Francis Olivier te | President and CEO | A | +74,277 deriv. | — |
| 2025-06-13 | Gloria F Basse | Director | M | +3,530 | +$16.98K |
| 2025-06-12 | Bryan K. Gathagan | Director | Buy | +1,000 | +$6.32K |
| 2025-04-23 | Timothy C Fiori | Chief Financial Officer | A | +30,000 deriv. | — |
| 2024-09-24 | Steven T. Rosgen | Director | A | +10,000 deriv. | — |
| 2024-09-24 | Paul R Wainman | Director | A | +10,000 deriv. | — |
| 2024-09-24 | David Scott Tomsche | Director | A | +10,000 deriv. | — |
| 2024-09-24 | Gloria F Basse | Director | A | +10,000 deriv. | — |
| 2024-09-24 | Bryan K. Gathagan | Director | A | +10,000 deriv. | — |
| 2024-08-30 | David Scott Tomsche | Director | D | +2,186 | +$7.76K |
| 2024-08-26 | David Scott Tomsche | Director | D | +6,005 | +$21.32K |
| 2024-08-22 | David Scott Tomsche | Director | D | +10,000 | +$35.50K |
| 2024-08-19 | David Scott Tomsche | Director | D | +10,000 | +$36.72K |
| 2023-09-06 | David Scott Tomsche | Director | D | +3,100 | +$14.74K |
| 2023-08-30 | Bryan K. Gathagan | Director | A | +15,000 deriv. | — |
| 2023-03-15 | David Scott Tomsche | Director | D | +4,080 | +$21.99K |
| 2023-01-24 | David Cunningham | Director | A | +10,000 deriv. | — |
| 2023-01-24 | Steven T. Rosgen | Director | A | +10,000 deriv. | — |
| 2023-01-24 | Gloria F Basse | Director | A | +10,000 deriv. | — |
| 2023-01-24 | Paul R Wainman | Director | A | +10,000 deriv. | — |
| 2023-01-24 | David Scott Tomsche | Director | A | +10,000 deriv. | — |
| 2022-09-12 | David Scott Tomsche | Director | D | +2,407 | +$18.62K |
| 2022-06-16 | David Scott Tomsche | Director | D | +4,900 | +$40.05K |
| 2022-06-14 | David Cunningham | Director | Buy | +1,000 | +$8.00K |
| 2022-05-18 | David Scott Tomsche | Director | D | +3,600 | +$30.13K |
| 2022-05-18 | David Scott Tomsche | Director | D | +3,600 | +$30.13K |
| 2022-03-14 | Joseph H Crabb | Former VP and CSO | D | +1,000 | +$5.84K |
| 2022-02-09 | Michael F Brigham | President & CEO | A | +1,000 deriv. | — |
| 2022-02-09 | Bobbi Jo Brockmann | VP of Sales & Marketing | A | +18,000 deriv. | — |
| 2022-02-09 | Elizabeth Luttrell Williams | VP of Manufacturing Operations | A | +1,000 deriv. | — |
| 2021-06-25 | Gloria F Basse | Director | A | +25,000 deriv. | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Michael F Brigham | President & CEO | 205,700 | $2.02M |
| David Scott Tomsche | Director | 57,460 | $563.11K |
| Boekhorst Paul Francis Olivier te | President and CEO | 17,785 | $174.29K |
| Bobbi Jo Brockmann | VP of Sales and Marketing | 8,521 | $83.51K |
| Paul R Wainman | Director | 6,269 | $61.44K |
| Gloria F Basse | Director | 3,530 | $34.59K |
| Bryan K. Gathagan | Director | 1,000 | $9.80K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the ICCC quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.